Always up to date
News
Here you will always find the latest news from us
The medical devices division at Winicker Norimed
January 21, 2025
Place your trust in expertise, precision and innovation: since our foundation in 1993, we have established ourselves as a renowned CRO in pharmaceutical research. We are proud to count global players as well as small and medium-sized pharmaceutical manufacturers among our satisfied customers..
...
Project management at Winicker Norimed
January 08, 2025
Every project tells its own story - and at Winicker Norimed we are proud to be part of these stories. Our goal is to turn your visions into reality.
What characterises our project management?
- Customer centricity: Your requirements are at the centre of everything we do. We adapt our approach flexibly to your individual needs - always taking national and international standards into account....
A successful and healthy new year 2025
January 02, 2025
The year 2024 lies behind us - a year full of challenges, but also full of valuable experiences and successes. As a company, we look back with pride at what we have achieved together and are full of drive and anticipation for what 2025 has in store for us.
2025 - a year of opportunities
In this new year, we are focussing on innovation, collaboration and growth. Exciting projects and ...
News 2024
Merry Christmas from Winicker Norimed GmbH
Dezember 17, 2024
The year 2024 is drawing to a close - a time to pause, look back and show gratitude. In this special moment, we at Winicker Norimed would like to thank all our partners, customers and colleagues for their trust and successful cooperation.
...
Leads workshop: Together into the future!
Dezember 03, 2024
What an inspiring time! Our newly formed management team retreated to the Hotel Riesengebirge in Neuhof an der Zenn for two days to work undisturbed on our shared management culture and provide valuable impetus. .
The trainer, Mr Rudolf Knauer, managed to meet each of us where we were. ...
BVMA Symposium 2024 | We were there!
November 26, 2024
On 22 November, the 32nd symposium of the BVMA took place with the title ‘Study Location Germany - New Impulses for Clinical Research’. Winicker Norimed was there with a team of 7 people.
The evening before, we were able to get into conversation with business partners, friends and companies in an informal atmosphere at the cosy get-together...
32nd BVMA Symposium
November 19, 2024
On 22 November 2024, the 32nd symposium of the German Association of Medical Contract Research Organisations BVMA will take place in Munich. The topic is ‘Study Location Germany - New Impulses for Clinical Research’. The symposium's exciting programme includes presentations and discussions on topics such as regulatory issues, digitalisation in clinical research, AI applications and opportunities....
Benefit Assessment and Successful Market Access
November 18, 2024
Our enhanced focus on AMNOG (German Pharmaceutical Market Reorganization Act), Health Technology Assessment (HTA), and Market Access. The demand for robust, evidence-based analyses and a transparent, comprehensible decision-making foundation regarding additional benefits is continuously growing. This ...
eCRF and ePRO
November 4, 2024
Digitalisation is becoming increasingly important in today's clinical research. Two central elements of this development are the electronic Case Report Forms (eCRF) and the electronic Patient Reported Outcomes (ePRO). Both concepts enable the efficient, secure and user-friendly collection, storage and analysis of clinical trial data. ...
5th KLIFO workshop from BPI & BVMA
Oktober 14, 2024
On 7 October 2024, the fifth KLIFO workshop of the BPI and BVMA took place in Berlin with the topic ‘How do I find the right CRO? How do sponsors and CROs come together?’ Winicker Norimed was represented by Wolfgang Bücherl.
Both sponsors and CROs described their views and requirements and then engaged in direct dialogue in working groups. Great importance is attached to selecting the ‘right’ service ...
Annual PV Congress in Cologne
September 27, 2024
Our colleagues Petra Hofmann and Susanne Böhmer dedicated themselves to further training at the beginning of this week and were in Cologne. The 12th annual Pharmacovigilance (PV) conference of the ChemAcademy took place here. This event has been regularly attended by colleagues from Winicker Norimed's Safety & Vigilance department for many years. ...
Artificial intelligence and medical writing
September 25, 2024
The idea that machines could replace human thinking and human intelligence is a very old one, but only modern computer technologies have helped to realise this idea to some extent. Traditional work processes and methods are changing drastically as a result. It is now impossible to imagine our language without AI, from ‘translation machines’ to chatbots.
The 3 most important things for a successful clinical trial
August 21, 2024
Clinical trials are essential for the development of new therapies, drugs and medical procedures. They not only help to evaluate the safety and efficacy of new treatments, but also contribute to the improvement of existing treatment standards. When conducting clinical trials, three key aspects are of central importance: ethical ...
White Party
August 05, 2024
On 26 July, our annual summer party was celebrated for the third time at the Gutmann with a panoramic view of the Dutzendteich. This year’s motto was: „White party in your best white outfit“. The entire WN team turned up in bright white, which gave the party a very special atmosphere. Plenty of food and drinks were provided and not only the sun, but also the outfits and exuberant …
Current trends in clinical research
August 01, 2024
Clinical research is in a constant state of
changing, driven by technological advances, regulatory changes and the
regulatory changes and the need for more efficient and patient-centred approaches.
Here are some of the most significant trends currently shaping clinical research
are currently shaping clinical research: ...
First-in-Human (FIH)
July 11, 2024
The world of medical research and development of drugs or medical devices is a constantly growing and evolving domain. A critical and important step in the authorisation process is the first trial on humans. These so-called first-in-human studies (also known as phase 1 studies in the case of medicinal products) are the first step in a multi-stage ...
Decentralized Clinical Trials
June 24, 2024
with the help of technology
In Germany, too, conventional study models in the field of clinical research are increasingly being supplemented or even replaced by innovative approaches. The focus of this change is on decentralised clinical trials, which are ...
Safety & Vigilance
June 11, 2024
... simply more than just pharmacovigilance
For over 10 years, the topic of Safety & Vigilance has been anchored in a separate department at Winicker Norimed. Starting out as a pure pharmacovigilance department we have been able to greatly expand our portfolio in line with the needs of our clients. …
Multiple sclerosis (MS)
May 28, 2024
… and the World MS Day 2024
Every year, around 15,000 people in Germany are diagnosed with MS. Initially a shock for all those affected. Many questions arise: What does life with MS mean? Where can I find help? With World MS Day, the German Multiple Sclerosis Society (DMSG) has created a framework to ...
Medical Writing Service
May 16, 2024
Improve the quality of your documents with our first-class medical writing service!
As an integral part of a medium-sized full-service CRO, we offer a wide range of medical writing services, which of course always meet the relevant regulatory requirements - our experienced team is at your side. ...
The Growth Opportunity Law
May 2, 2024
Its significance for clinical research
The Growth Opportunity Law, also known as the "Law to Strengthen Growth Opportunities, Investments, and Innovation as well as Tax Simplification and Tax Fairness," is a groundbreaking legislative initiative in challenging economic times. With the aim of enhancing the innovation capacity and ...
DMEA Berlin
April 18, 2024
Connecting Digital Health
From April 9th to 11th, 2024, Europe's leading event for Digital Health took place in Berlin. Here, experts from the digital health industry gathered, among others. The DMEA offered all stakeholders an informative exchange on various facets of digitization in healthcare. Additionally, there were exciting encounters, for example, with the Federal Minister of Health, Karl Lauterbach...
Introducing the Job Bike
April 4, 2024
Sustainable Alternative for Our Team
More and more companies are recognizing the importance of sustainability and health in the workplace. An innovative solution that combines both aspects is the introduction of #JobBike. And that's exactly what we've done at #Winicker Norimed. We are very excited to offer our employees...
Decentralized Clinical Trials
March 18, 2024
Home Visit Staff Providing Relief
In decentralized trial models, subjects are no longer exclusively treated at specialized study centers but can participate in the study from home, in their familiar environment. This is intended to increase both the willingness and the opportunities for study participation. In addition to a greater diversity of patients in the study ...
Winicker Norimed GmbH
Deutschherrnstraße 15-19
90429 Nuremberg
Phone: +49 (0) 911 / 9 26 80 - 0
E-Mail: info@winicker-norimed.com